I. Ioshin, A. Tolchinskaya, A. V. Rakova, E. A. Beresenko
{"title":"原发性开角型青光眼白内障治疗的前景","authors":"I. Ioshin, A. Tolchinskaya, A. V. Rakova, E. A. Beresenko","doi":"10.25276/0235-4160-2023-2-13-18","DOIUrl":null,"url":null,"abstract":"Purpose. To evaluate a two-stage approach to surgical treatment of patients with cataract and primary open-angle glaucoma based on micropulse transscleral cyclophotocoagulation (MP-TSCPC) and phacoemulsification. Material and methods. The results of surgical treatment of 34 patients with cataract and primary open-angle glaucoma with non-dispersed intraocular pressure (IOP) were analyzed. A safer sequential surgery was chosen: at the first stage, MP-TSCPC was performed, at the second – cataract phacoemulsification. Results. After MP-TSCPC, the hypotensive effect was achieved in all 34 patients: IOP at the moderate stage was 14.6±1,4 mm Hg, at the advanced stage – 15.8±2,2 mm Hg. 1 month after surgery. Carrying out the second stage – phacoemulsification of cataracts 2–4 weeks after MP-TSCPC allowed to avoid reactive hypertension and achieve high functional results. IOP from the first day was 13.8±1,0 mm Hg in patients with moderate stage and 14.9±3,1 mm Hg in patients with advanced stage and remained compensated for 3 months after surgery. Visual acuity 3 months after surgery was 0.85±0.05 in patients with moderate and 0.73±0.05 with advanced stage. Anti-inflammatory prevention based on 0.1% fluorometholone acetate solution, considering the minimal effect on the IOP of the operated eye, showed promising advantages over other glucocorticoids for patients with glaucoma and cataracts. Conclusion. Sequential surgery with MP-TSCPC at the first stage and following phacoemulsification (against the background of stabilized IOP) is characterized by high functional results and minimal risk of complications in patients with comorbid pathology. Anti-inflammatory prevention based on 0.1% fluorometholone acetate solution, considering the minimal effect on IOP of the operated eye, has promising advantages for patients with glaucoma and cataracts. Key words: open-angle glaucoma, intraocular pressure, complicated cataract, micropulse cyclophotocoagulation, phacoemulsification","PeriodicalId":424200,"journal":{"name":"Fyodorov journal of ophthalmic surgery","volume":"702 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Promising approaches of cataract treatment in patients with primary open-angle glaucoma\",\"authors\":\"I. Ioshin, A. Tolchinskaya, A. V. Rakova, E. A. Beresenko\",\"doi\":\"10.25276/0235-4160-2023-2-13-18\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Purpose. To evaluate a two-stage approach to surgical treatment of patients with cataract and primary open-angle glaucoma based on micropulse transscleral cyclophotocoagulation (MP-TSCPC) and phacoemulsification. Material and methods. The results of surgical treatment of 34 patients with cataract and primary open-angle glaucoma with non-dispersed intraocular pressure (IOP) were analyzed. A safer sequential surgery was chosen: at the first stage, MP-TSCPC was performed, at the second – cataract phacoemulsification. Results. After MP-TSCPC, the hypotensive effect was achieved in all 34 patients: IOP at the moderate stage was 14.6±1,4 mm Hg, at the advanced stage – 15.8±2,2 mm Hg. 1 month after surgery. Carrying out the second stage – phacoemulsification of cataracts 2–4 weeks after MP-TSCPC allowed to avoid reactive hypertension and achieve high functional results. IOP from the first day was 13.8±1,0 mm Hg in patients with moderate stage and 14.9±3,1 mm Hg in patients with advanced stage and remained compensated for 3 months after surgery. Visual acuity 3 months after surgery was 0.85±0.05 in patients with moderate and 0.73±0.05 with advanced stage. Anti-inflammatory prevention based on 0.1% fluorometholone acetate solution, considering the minimal effect on the IOP of the operated eye, showed promising advantages over other glucocorticoids for patients with glaucoma and cataracts. Conclusion. Sequential surgery with MP-TSCPC at the first stage and following phacoemulsification (against the background of stabilized IOP) is characterized by high functional results and minimal risk of complications in patients with comorbid pathology. Anti-inflammatory prevention based on 0.1% fluorometholone acetate solution, considering the minimal effect on IOP of the operated eye, has promising advantages for patients with glaucoma and cataracts. Key words: open-angle glaucoma, intraocular pressure, complicated cataract, micropulse cyclophotocoagulation, phacoemulsification\",\"PeriodicalId\":424200,\"journal\":{\"name\":\"Fyodorov journal of ophthalmic surgery\",\"volume\":\"702 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-06-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Fyodorov journal of ophthalmic surgery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.25276/0235-4160-2023-2-13-18\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Fyodorov journal of ophthalmic surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25276/0235-4160-2023-2-13-18","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
目的。目的:探讨微脉冲经巩膜光凝术(MP-TSCPC)和超声乳化术两阶段手术治疗白内障合并原发性开角型青光眼的方法。材料和方法。分析34例白内障合并原发性开角型青光眼伴非分散眼压的手术治疗结果。选择了更安全的顺序手术:第一阶段行MP-TSCPC,第二阶段行白内障超声乳化术。结果。MP-TSCPC术后34例患者均达到降压效果:术后1个月,中期IOP为14.6±1.4 mm Hg,晚期IOP为15.8±2.2 mm Hg。MP-TSCPC术后2-4周行第二阶段白内障超声乳化术,可避免反应性高血压,达到较高的功能效果。中期患者第一天的IOP为13.8±0.1 mm Hg,晚期患者为14.9±3.1 mm Hg,术后3个月仍保持代偿。中度患者术后3个月视力0.85±0.05,晚期患者术后3个月视力0.73±0.05。考虑到0.1%醋酸氟美洛酮溶液对手术眼的IOP影响最小,对青光眼和白内障患者的抗炎预防比其他糖皮质激素有更大的优势。结论。在第一阶段和随后的超声乳化术(在IOP稳定的背景下)进行MP-TSCPC的序贯手术的特点是高功能结果和并发症风险最小的合并症患者。基于0.1%醋酸氟美洛酮溶液的抗炎预防,考虑到对手术眼的IOP影响最小,对青光眼和白内障患者具有很好的优势。关键词:开角型青光眼,眼压,并发白内障,微脉冲光凝,超声乳化
Promising approaches of cataract treatment in patients with primary open-angle glaucoma
Purpose. To evaluate a two-stage approach to surgical treatment of patients with cataract and primary open-angle glaucoma based on micropulse transscleral cyclophotocoagulation (MP-TSCPC) and phacoemulsification. Material and methods. The results of surgical treatment of 34 patients with cataract and primary open-angle glaucoma with non-dispersed intraocular pressure (IOP) were analyzed. A safer sequential surgery was chosen: at the first stage, MP-TSCPC was performed, at the second – cataract phacoemulsification. Results. After MP-TSCPC, the hypotensive effect was achieved in all 34 patients: IOP at the moderate stage was 14.6±1,4 mm Hg, at the advanced stage – 15.8±2,2 mm Hg. 1 month after surgery. Carrying out the second stage – phacoemulsification of cataracts 2–4 weeks after MP-TSCPC allowed to avoid reactive hypertension and achieve high functional results. IOP from the first day was 13.8±1,0 mm Hg in patients with moderate stage and 14.9±3,1 mm Hg in patients with advanced stage and remained compensated for 3 months after surgery. Visual acuity 3 months after surgery was 0.85±0.05 in patients with moderate and 0.73±0.05 with advanced stage. Anti-inflammatory prevention based on 0.1% fluorometholone acetate solution, considering the minimal effect on the IOP of the operated eye, showed promising advantages over other glucocorticoids for patients with glaucoma and cataracts. Conclusion. Sequential surgery with MP-TSCPC at the first stage and following phacoemulsification (against the background of stabilized IOP) is characterized by high functional results and minimal risk of complications in patients with comorbid pathology. Anti-inflammatory prevention based on 0.1% fluorometholone acetate solution, considering the minimal effect on IOP of the operated eye, has promising advantages for patients with glaucoma and cataracts. Key words: open-angle glaucoma, intraocular pressure, complicated cataract, micropulse cyclophotocoagulation, phacoemulsification